Welcome to LookChem.com Sign In|Join Free

CAS

  • or

351343-80-1

Post Buying Request

351343-80-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

351343-80-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 351343-80-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,1,3,4 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 351343-80:
(8*3)+(7*5)+(6*1)+(5*3)+(4*4)+(3*3)+(2*8)+(1*0)=121
121 % 10 = 1
So 351343-80-1 is a valid CAS Registry Number.

351343-80-1Relevant articles and documents

Controlled Reduction of Nitriles by Sodium Hydride and Zinc Chloride

Chiba, Shunsuke,Ong, Derek Yiren

, p. 1369 - 1378 (2020/04/27)

A new protocol for the controlled reduction of nitriles to aldehydes was developed using a combination of sodium hydride and zinc chloride. The iminyl zinc intermediates derived from aromatic nitriles could be further functionalized with allylmetal nucleophiles to afford homoallylamines. As the method allows the reduction of various aliphatic and aromatic nitriles with a concise procedure under milder reaction conditions and exhibits wide functional group compatibility, it is well suited for use in various opportunities in chemical synthesis.

Fe-catalyzed regiodivergent [1,2]-shift of α-aryl aldehydes

Gutierrez-Bonet, Alvaro,Flores-Gaspar, Areli,Martin, Ruben

supporting information, p. 12576 - 12579 (2013/09/23)

An Fe-catalyzed conversion of aldehydes to ketones via [1,2]-shift has been developed. This skeletal rearrangement shows a wide substrate scope and chemoselectivity profile while exhibiting an excellent [1,2]-aryl or [1,2]-alkyl shift selectivity that is easily switched by electronic effects.

TRICYCLIC HETEROCYCLIC COMPOUNDS

-

Page/Page column 88, (2011/06/16)

Disclosed are compounds of Formula (I) or stereoisomers or salts thereof, wherein: X1, X2, X3, W, Q1, Q2, and G2 are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 351343-80-1